Ioanna Smyrlaki

Artiklar

Article: NATURE COMMUNICATIONS. 2020;11(1):4812
Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR
Smyrlaki I; Ekman M; Lentini A; de Sousa NR; Papanicolaou N; Vondracek M; Aarum J; Safari H; Muradrasoli S; Rothfuchs AG; Albert J; Hoegberg B; Reinius B
Article: NATURE NANOTECHNOLOGY. 2019;14(2):184-190
Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies
Shaw A; Hoffecker IT; Smyrlaki I; Rosa J; Grevys A; Bratlie D; Sandlie I; Michaelsen TE; Andersen JT; Hogberg B
Article: MATRIX BIOLOGY. 2014;35:182-193
Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans.
Skandalis SS; Afratis N; Smirlaki G; Nikitovic D; Theocharis AD; Tzanakakis GN; Karamanos NK

Thesis / dissertation: 2022
Nucleic acid tools for detection and characterization of biological systems
Smyrlaki, Ioanna
Corrigendum: NATURE NANOTECHNOLOGY. 2019;14(4):398
Publisher Correction: Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies.
Shaw A; Hoffecker IT; Smyrlaki I; Rosa J; Grevys A; Bratlie D; Sandlie I; Michaelsen TE; Andersen JT; Högberg B
Review: FRONTIERS IN ONCOLOGY. 2014;3:327
Serglycin: at the crossroad of inflammation and malignancy.
Korpetinou A; Skandalis SS; Labropoulou VT; Smirlaki G; Noulas A; Karamanos NK; Theocharis AD
Review: BIOMED RESEARCH INTERNATIONAL. 2013;2013:230805-18
Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome.
Syggelos SA; Aletras AJ; Smirlaki I; Skandalis SS

Anknuten till Forskning, Medicinsk biokemi och biofysik, Karolinska Institutet, 2023-2025
Postdoktor, Medicinsk biokemi och biofysik, Karolinska Institutet, 2023-2024

Medicine Doktorsexamen, Institutionen för medicinsk biokemi och biofysik, Karolinska Institutet, 2023